ZKIN vs MTUS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

ZKIN

50.2
AI Score
VS
ZKIN Wins

MTUS

39.9
AI Score

Investment Advisor Scores

ZKIN

50score
Recommendation
HOLD

MTUS

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ZKIN MTUS Winner
Forward P/E 0 14.43 Tie
PEG Ratio 0 0.9617 Tie
Revenue Growth -43.5% 10.2% MTUS
Earnings Growth -97.7% 189.5% MTUS
Tradestie Score 50.2/100 39.9/100 ZKIN
Profit Margin -28.0% 1.9% MTUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ZKIN

Relative Price Performance (Last 90 Days)

ZKIN 1M: -10.9% · 3M: +42.4% MTUS 1M: -15.6% · 3M: -19.9%

Current Technical Phase

ZKIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.2% over 20 days), RSI 51

RSI (14): 50.7 · Price: $1.55

MTUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $17.46

Fundamentals Snapshot

Metric ZKIN MTUS
Market Cap — —
Forward P/E 0.0 13.7
Trailing P/E — 31.9
Revenue (TTM) — —
Revenue Growth -0.4% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin -8.0% 0.1%
EPS -1.44 0.55
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.